If you’re an executive or other key employee, you might be
rewarded for your contributions to your company’s success with compensation
such as restricted stock, stock options or nonqualified deferred compensation
(NQDC). Tax planning for these forms of “exec comp,” however, is generally more
complicated than for salaries, bonuses and traditional employee benefits.
And planning gets even more complicated if you could potentially
be subject to two taxes under the Affordable Care Act (ACA): 1) the additional
0.9% Medicare tax, and 2) the net investment income tax (NIIT). These taxes
apply when certain income exceeds the applicable threshold: $250,000 for
married filing jointly, $125,000 for married filing separately, and $200,000
for other taxpayers.
Additional Medicare tax
The following types of exec comp could be subject to the
additional 0.9% Medicare tax if your earned income exceeds the applicable
threshold:
- Fair market value (FMV) of restricted stock once the
stock is no longer subject to risk of forfeiture or it’s sold,
- FMV of restricted stock when it’s awarded if you make a
Section 83(b) election,
- Bargain element of nonqualified stock options when
exercised, and
- Nonqualified deferred compensation once the services
have been performed and there’s no longer a substantial risk of
forfeiture.
NIIT
The following types of gains from stock acquired through exec
comp will be included in net investment income and could be subject to the 3.8%
NIIT if your modified adjusted gross income (MAGI) exceeds the applicable
threshold:
- Gain on the sale of restricted stock if you’ve made the
Sec. 83(b) election, and
- Gain on the sale of stock from an incentive stock
option exercise if you meet the holding requirements.
Keep in mind that the additional Medicare tax and the NIIT could
possibly be eliminated under tax reform or ACA-related legislation. If you’re
concerned about how your exec comp will be taxed, please contact us. We can
help you assess the potential tax impact and implement strategies to reduce it.
© 2017
No comments:
Post a Comment